tiprankstipranks

Joseph P Lyssikatos Insider Profile

4 Followers
Joseph P Lyssikatos, CSO, Director at Enliven Therapeutics, holds 1.12M shares in Enliven Therapeutics (Ticker: ELVN).
tipranks
Joseph P Lyssikatos

Joseph P Lyssikatos
Enliven Therapeutics (ELVN)
CSO, Director

Not Ranked
Joseph P Lyssikatos has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$28M
100.00%
A breakdown of Joseph P Lyssikatos's holdings

Insider Roles

Enliven Therapeutics
(ELVN)
CSO, Director
Roles that Joseph P Lyssikatos holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Joseph P Lyssikatos

Joseph P Lyssikatos's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Enliven Therapeutics
May 01, 2024
CSO, Director
Uninformative Sell
214.95K
$27.59M
Joseph P Lyssikatos has not reported any informative transactions for ELVN, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Feb 27, 2023
Uninformative Buy
$0.00
-
$0.00
Oct 03, 2023
Uninformative Sell
$163.44K
-
$1.12
Nov 06, 2023
Uninformative Sell
$111.70K
-
$1.12
Dec 21, 2023
Uninformative Sell
$115.63K
-
$1.12
Dec 26, 2023
Uninformative Sell
$85.75K
-
$1.12
List of latest transactions for each holding click on a transaction to see Joseph P Lyssikatos's performance on stock

Joseph P Lyssikatos insider profile FAQ

What is the percentage of profitable transactions made by Joseph P Lyssikatos?
The percentage of profitable transactions made by Joseph P Lyssikatos is ―.
    What is the average return per transaction made by Joseph P Lyssikatos?
    The average return per transaction made by Joseph P Lyssikatos is ―.
      What stocks does Joseph P Lyssikatos hold?
      Joseph P Lyssikatos holds: ELVN stocks.
        What was Joseph P Lyssikatos’s latest transaction?
        Joseph P Lyssikatos latest transaction was an Uninformative Sell of $214.95K.
          What was Joseph P Lyssikatos's most profitable transaction?
          Joseph P Lyssikatos’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Joseph P Lyssikatos's role in Enliven Therapeutics?
            Joseph P Lyssikatos's role in Enliven Therapeutics is CSO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.